Several presentations last week at the American Society of Clinical Oncology (ASCO) Breast Cancer Symposium in San Francisco addressed important questions in triple-negative breast cancer: Are there promising new treatment approaches for these breast cancer patients, and how can we identify which patients are high risk?
http://www.cancernetwork.com/conference-reports/asco2012/breast-cancer-symposium/content/article/10165/2103122
(Click link for full story)
http://www.cancernetwork.com/conference-reports/asco2012/breast-cancer-symposium/content/article/10165/2103122
(Click link for full story)